The role of CD40 in ulcerative colitis

Histochemical analysis and clinical correlation

Lino Polese, Imerio Angriman, Attilio Cecchetto, Lorenzo Norberto, Marco Scarpa, Cesare Ruffolo, Michela Barollo, Antonio Sommariva, Davide F. D'Amico

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Objectives: CD40 co-stimulator seems to be implicated in the loss of tolerance against self-antigens in many autoimmune diseases. The evidence suggests that in the pathogenesis of ulcerative colitis there is an activity state against self-antigens of the gut wall and flora. The aim of this study was to analyse the expression of CD40 in ulcerative colitis, comparing it with Crohn's disease and nonspecific inflammation of the colon and to determine whether there is a relationship between its expression and the activity stage of the disease. Methods: The expression of CD40 in the colonic samples of 51 patients (30 ulcerative colitis, 9 Crohn's disease and 12 nonspecific inflammation) was analysed by immunohistochemistry, Twenty-four patients with ulcerative colitis were scored according to clinical, endoscopic and histological classification. Results: The mean percentage of CD40+ cells per field in the colonic mucosa was: ulcerative colitis 21 ± 11%, Crohn's disease 24 ± 9%, nonspecific inflammation 7 ± 7%. The ulcerative colitis patients were statistically significantly different compared to the patients with nonspecific inflammation (P

Original languageEnglish
Pages (from-to)237-241
Number of pages5
JournalEuropean Journal of Gastroenterology and Hepatology
Volume14
Issue number3
DOIs
Publication statusPublished - 2002

Fingerprint

Ulcerative Colitis
Crohn Disease
Inflammation
Autoantigens
Autoimmune Diseases
Colon
Mucous Membrane
Immunohistochemistry

Keywords

  • Activity
  • CD40
  • Crohn's disease
  • Immunohistochemistry
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

The role of CD40 in ulcerative colitis : Histochemical analysis and clinical correlation. / Polese, Lino; Angriman, Imerio; Cecchetto, Attilio; Norberto, Lorenzo; Scarpa, Marco; Ruffolo, Cesare; Barollo, Michela; Sommariva, Antonio; D'Amico, Davide F.

In: European Journal of Gastroenterology and Hepatology, Vol. 14, No. 3, 2002, p. 237-241.

Research output: Contribution to journalArticle

Polese, Lino ; Angriman, Imerio ; Cecchetto, Attilio ; Norberto, Lorenzo ; Scarpa, Marco ; Ruffolo, Cesare ; Barollo, Michela ; Sommariva, Antonio ; D'Amico, Davide F. / The role of CD40 in ulcerative colitis : Histochemical analysis and clinical correlation. In: European Journal of Gastroenterology and Hepatology. 2002 ; Vol. 14, No. 3. pp. 237-241.
@article{3c09bc74a9e24dc1864fe4e4f98aa1ae,
title = "The role of CD40 in ulcerative colitis: Histochemical analysis and clinical correlation",
abstract = "Objectives: CD40 co-stimulator seems to be implicated in the loss of tolerance against self-antigens in many autoimmune diseases. The evidence suggests that in the pathogenesis of ulcerative colitis there is an activity state against self-antigens of the gut wall and flora. The aim of this study was to analyse the expression of CD40 in ulcerative colitis, comparing it with Crohn's disease and nonspecific inflammation of the colon and to determine whether there is a relationship between its expression and the activity stage of the disease. Methods: The expression of CD40 in the colonic samples of 51 patients (30 ulcerative colitis, 9 Crohn's disease and 12 nonspecific inflammation) was analysed by immunohistochemistry, Twenty-four patients with ulcerative colitis were scored according to clinical, endoscopic and histological classification. Results: The mean percentage of CD40+ cells per field in the colonic mucosa was: ulcerative colitis 21 ± 11{\%}, Crohn's disease 24 ± 9{\%}, nonspecific inflammation 7 ± 7{\%}. The ulcerative colitis patients were statistically significantly different compared to the patients with nonspecific inflammation (P",
keywords = "Activity, CD40, Crohn's disease, Immunohistochemistry, Ulcerative colitis",
author = "Lino Polese and Imerio Angriman and Attilio Cecchetto and Lorenzo Norberto and Marco Scarpa and Cesare Ruffolo and Michela Barollo and Antonio Sommariva and D'Amico, {Davide F.}",
year = "2002",
doi = "10.1097/00042737-200203000-00006",
language = "English",
volume = "14",
pages = "237--241",
journal = "European Journal of Gastroenterology and Hepatology",
issn = "0954-691X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - The role of CD40 in ulcerative colitis

T2 - Histochemical analysis and clinical correlation

AU - Polese, Lino

AU - Angriman, Imerio

AU - Cecchetto, Attilio

AU - Norberto, Lorenzo

AU - Scarpa, Marco

AU - Ruffolo, Cesare

AU - Barollo, Michela

AU - Sommariva, Antonio

AU - D'Amico, Davide F.

PY - 2002

Y1 - 2002

N2 - Objectives: CD40 co-stimulator seems to be implicated in the loss of tolerance against self-antigens in many autoimmune diseases. The evidence suggests that in the pathogenesis of ulcerative colitis there is an activity state against self-antigens of the gut wall and flora. The aim of this study was to analyse the expression of CD40 in ulcerative colitis, comparing it with Crohn's disease and nonspecific inflammation of the colon and to determine whether there is a relationship between its expression and the activity stage of the disease. Methods: The expression of CD40 in the colonic samples of 51 patients (30 ulcerative colitis, 9 Crohn's disease and 12 nonspecific inflammation) was analysed by immunohistochemistry, Twenty-four patients with ulcerative colitis were scored according to clinical, endoscopic and histological classification. Results: The mean percentage of CD40+ cells per field in the colonic mucosa was: ulcerative colitis 21 ± 11%, Crohn's disease 24 ± 9%, nonspecific inflammation 7 ± 7%. The ulcerative colitis patients were statistically significantly different compared to the patients with nonspecific inflammation (P

AB - Objectives: CD40 co-stimulator seems to be implicated in the loss of tolerance against self-antigens in many autoimmune diseases. The evidence suggests that in the pathogenesis of ulcerative colitis there is an activity state against self-antigens of the gut wall and flora. The aim of this study was to analyse the expression of CD40 in ulcerative colitis, comparing it with Crohn's disease and nonspecific inflammation of the colon and to determine whether there is a relationship between its expression and the activity stage of the disease. Methods: The expression of CD40 in the colonic samples of 51 patients (30 ulcerative colitis, 9 Crohn's disease and 12 nonspecific inflammation) was analysed by immunohistochemistry, Twenty-four patients with ulcerative colitis were scored according to clinical, endoscopic and histological classification. Results: The mean percentage of CD40+ cells per field in the colonic mucosa was: ulcerative colitis 21 ± 11%, Crohn's disease 24 ± 9%, nonspecific inflammation 7 ± 7%. The ulcerative colitis patients were statistically significantly different compared to the patients with nonspecific inflammation (P

KW - Activity

KW - CD40

KW - Crohn's disease

KW - Immunohistochemistry

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=0036201566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036201566&partnerID=8YFLogxK

U2 - 10.1097/00042737-200203000-00006

DO - 10.1097/00042737-200203000-00006

M3 - Article

VL - 14

SP - 237

EP - 241

JO - European Journal of Gastroenterology and Hepatology

JF - European Journal of Gastroenterology and Hepatology

SN - 0954-691X

IS - 3

ER -